Report Overview

The EU Rheumatology Therapeutics market size stood at round USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Rheumatology is the discipline of internal medicine that involves the diagnosis and treatment of rheumatic diseases. Rheumatic diseases are characterized by the inflammation that affects joints, tendons, ligaments, bones and sometimes organs. Rheumatic diseases are also called as musculoskeletal disease causes severe pain, deformity and morbidity and leads to heavy economic burden due to high cost of treatment. There are more than 100 different types of rheumatic diseases with different symptoms and the symptoms of these diseases to all age groups



Market Drivers

The increasing prevalence of rheumatology, the launch of novel therapeutic agents, and favorable reimbursement policies for high-cost treatment products are some of the factors that are driving the growth of European rheumatology therapeutics market